Interestingly, IL-6R neutralization negatively regulates angiogenesis and tumor growth through IL-6 signaling downregulation, supporting the hypothesis that considers IL-6 signaling proteins to be useful targets in CRC therapy [17,61] and in several other human diseases [49]. This evidence concerns the gene IL6 and neoplasm.